MindMaze Therapeutics Holding SA / Key word(s): MiscellaneousMindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor12.08.2026 / 07:00 CET/CESTMindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor Geneva, Switzerland - August 12, 2026 - MindMaze Therapeutics Holding SA (SIX: MMTX ) (MindMaze Therapeutics or the Company), a global leader in scalable precision neurotherapeutics, today announced that Dr. John Krakauer has joined the Company as a strategic advisor to support its next phase of growth in the United States. Dr. John Krakauer is the original scientific creator of MindPod, MindMaze Therapeutics' precision upper-limb rehabilitation system, and one of the world's most cited researchers in motor neuroscience, stroke recovery, and neurorehabilitation. With an extensive library of rigorous clinical validation and a robust R&D pipeline, MindMaze Therapeutics is operationalizing the future of neurorestorative medicine. This communication is provided as of the date hereof, and MindMaze Therapeutics undertakes no obligation to update any forward-looking statements contained herein as a result of new information, future events or otherwise. Additional features:File: Press release_MindMaze_John Krakauer Strategic AdvisorEnd of Media ReleaseView original content: EQS News